Sort by
Refine Your Search
-
You'll Bring Required Qualifications PhD or equivalent doctoral degree (ScD, MD, DVM, or related terminal degree). Strong background in one or more of the following: Computer Vision Machine Learning
-
discoveries made in the laboratory with meaningful improvements in patient care. You will be part of a research environment that values curiosity, creativity, scientific rigor, and continuous learning while
-
. The successful applicant will possess a PhD or equivalent doctoral degree in the social sciences, including political science, public policy, political ecology, law, geography or another relevant field with some
-
. Knowledge of survival analysis. Knowledge of machine learning methods. Other Requirements Application materials must include: Curriculum Vitae (CV) Statement of research interests Names of three professional
-
meetings, contribute to grant applications, and build an independent research career in cancer immunology and neuro-oncology. Minimum Requirements PhD, MD, MD/PhD, or equivalent doctoral degree in immunology
-
, measurement, and evaluation strategy, with a focus on cross-sector data infrastructure, linkage, performance measurement, evaluation, and continuous learning. Responsibilities: 1. Serve as a scientific partner
-
. or equivalent doctorate (e.g. Sc.D., M.D., D.V.M.) Preferred Qualifications:. A PhD or MD/PhD (or equivalent) in biological sciences Strong research background in cell biology, molecular biology, mouse models
-
of vaccine and therapeutic candidates currently being produced in Good Manufacturing Practice facilities for early phase clinical trials. Minimum Requirements: Education: PhD in Immunology, Data Science and/or
-
development of machine learning tools and their applications to medical imaging. Key Responsibilities: The Post Doctoral Associate will apply their technical skills toward the development, implementation, and
-
acquire new technical expertise as needed. Participate in clinical research efforts involving retrieval, processing, and molecular analysis of patient-derived specimens from prospective clinical trials